Corvus Pharmaceuticals Newsroom

H.C. Wainwright Initiates Corvus Pharmaceuticals(CRVS.US) With Buy Rating

Futu NewsJan 2 23:31

Corvus Pharma Analyst Ratings

BenzingaJan 2 20:01

Citi Initiates Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Announces Target Price $11

Futu NewsJan 2 19:31

Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS) and Veru (VERU)

TipRanksJan 2 19:26

Oppenheimer Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Maintains Target Price $14

Futu NewsDec 21, 2024 02:44

Mizuho Securities Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Announces Target Price $12

Futu NewsDec 19, 2024 18:31

A Quick Look at Today's Ratings for Corvus Pharmaceuticals(CRVS.US), With a Forecast Between $13 to $24

Futu NewsNov 14, 2024 21:05

Corvus Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow JonesNov 13, 2024 22:52

Corvus Pharma Analyst Ratings

BenzingaNov 13, 2024 22:42

Corvus Stock Climbs 7% Following Mizuho Upgrade

Seeking AlphaOct 22, 2024 23:52

Mizuho Securities Upgrades Corvus Pharmaceuticals(CRVS.US) to Buy Rating, Announces Target Price $12

Futu NewsOct 22, 2024 18:37

Corvus Pharma Analyst Ratings

BenzingaSep 17, 2024 00:38

Ladenburg Thalmann Maintains Buy on Corvus Pharma, Raises Price Target to $21

BenzingaSep 17, 2024 00:38

Ladenburg Thalmann Maintains Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Raises Target Price to $21

Futu NewsSep 16, 2024 19:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Corvus Pharmaceuticals (CRVS), Vir Biotechnology (VIR) and Cooper Co (COO)

TipRanksAug 20, 2024 18:54

Corvus Pharma Analyst Ratings

BenzingaMay 7, 2024 20:10

Corvus Pharma Analyst Ratings

BenzingaApr 1, 2024 23:20

Hold Rating Maintained for Corvus Pharmaceuticals Amid Clinical Delays and Financing Concerns

TipRanksMar 29, 2024 16:30

Corvus Pharma Analyst Ratings

BenzingaMar 28, 2024 01:25

Corvus Pharma Analyst Ratings

BenzingaMar 20, 2024 19:15